
Sector: Healthcare
ID_MIKA
Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.
Shares: connector/market_inputs
Monetary columns are in B IDR, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.
| Date | Period | Status | RevenueB IDR | Operating profitB IDR | D&AB IDR | EBITDAB IDR | Net profitB IDR | Operating CFB IDR | Capex + M&AB IDR | AssetsB IDR | EquityB IDR | ROE (annualized) | Net debtB IDR | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Q2 2026 (3M) | PARTIAL | 1.4 y/y — | 0.5 y/y — | 0.1 y/y — | 0.6 y/y — | 0.4 y/y — | — | — | 10.0 y/y — | 7.3 y/y — | 18.4% | -2.8 | Report (PDF) |
| 2026-03-31 | Q1 2026 (3M) | OK | 1.4 y/y 6.6% | 0.4 y/y 4.4% | 0.1 y/y 20.6% | 0.5 y/y 7.1% | 0.3 y/y 4.8% | 0.4 | -237.4 | 9.6 y/y 10.5% | 7.6 y/y 11.3% | 16.5% | -2.1 | Report (PDF) |
| 2025-12-31 | Q4 2025 (3M) | OK | 1.4 y/y 10.5% | 0.4 y/y 10.4% | 0.1 y/y -53.4% | 0.5 y/y -10.4% | 0.3 y/y 27.2% | 0.6 | -373.5 | 9.3 y/y 12.4% | 8.2 y/y 25.8% | 17.1% | -2.5 | Report (PDF) |
| 2025-09-30 | Q3 2025 (3M) | OK | 1.4 y/y 21.5% | 0.5 y/y 38.2% | 0.1 y/y 98.7% | 0.6 y/y 44.8% | 0.4 y/y 38.5% | 0.6 | -219.3 | 8.9 y/y 12.8% | 7.8 y/y 10.7% | 6.6% | -1.9 | Link |
| 2025-06-30 | Q2 2025 (3M) | OK | 1.3 y/y 6.8% | 0.4 y/y 5.7% | 0.1 y/y 0.0% | 0.5 y/y 4.7% | 0.3 y/y 5.5% | 0.3 | -173.9 | 9.0 y/y 11.5% | 7.4 y/y 9.3% | 18.5% | -2.2 | Link |
| 2025-03-31 | Q1 2025 (3M) | OK | 1.3 y/y 2.3% | 0.4 y/y 1.2% | 0.1 y/y 6.4% | 0.5 y/y 2.1% | 0.3 y/y 7.6% | 0.4 | -208.5 | 8.7 y/y 11.9% | 6.8 y/y 11.4% | 18.7% | -1.7 | Report (PDF) |
| 2024-12-31 | Q4 2024 (3M) | OK | 1.3 y/y — | 0.4 y/y — | 0.2 y/y — | 0.6 y/y — | 0.3 y/y — | 0.5 | -209.4 | 8.2 y/y — | 6.5 y/y — | 16.9% | -1.1 | Report (PDF) |
| 2024-09-30 | Q3 2024 (3M) | OK | 1.2 y/y 5.3% | 0.3 y/y 5.4% | 0.0 y/y -37.6% | 0.4 y/y -1.9% | 0.3 y/y -57.5% | 0.5 | -142.5 | 7.9 y/y 11.2% | 7.1 y/y 11.4% | 5.2% | -1.5 | Link |
| 2024-06-30 | Q2 2024 (3M) | OK | 1.2 y/y 18.4% | 0.4 y/y 36.7% | 0.1 y/y -59.1% | 0.5 y/y -2.2% | 0.3 y/y — | 0.4 | -252.1 | 8.1 y/y 19.4% | 6.8 y/y 11.4% | 19.3% | -1.7 | Link |
| 2024-03-31 | Q1 2024 (3M) | OK | 1.2 y/y — | 0.4 y/y — | 0.1 y/y — | 0.5 y/y — | 0.3 y/y — | 0.4 | -94.5 | 7.8 y/y — | 6.1 y/y — | 18.2% | -1.8 | Report (PDF) |
| 2023-12-31 | Q4 2023 (3M) | OK | 1.1 y/y — | 0.3 y/y — | 0.1 y/y — | 0.4 y/y — | -0.4 y/y — | 0.4 | -12.7 | 7.3 y/y — | 6.6 y/y — | 14.2% | — | Link |
| 2023-09-30 | Q3 2023 (3M) | OK | 1.1 y/y — | 0.3 y/y — | -0.1 y/y — | 0.4 y/y — | 0.8 y/y — | 0.3 | -76.1 | 7.1 y/y — | 6.3 y/y — | 13.8% | — | Link |
| 2023-06-30 | Q2 2023 (3M) | OK | 1.0 y/y — | 0.3 y/y — | 0.2 y/y — | 0.5 y/y — | -0.2 y/y — | 0.0 | -68.6 | 6.7 y/y — | 6.1 y/y — | — | — | Link |
| Short-term debt (incl. ST leases) | 1 |
| Long-term debt (incl. LT leases) | 8 |
| − Cash & equivalents | 2 852 |
| Net debt | -2 843 |
|---|
Net debt / LTM EBITDA: -1.4x
Quarterly values ($ mln)
Year-over-year change
FCF ($ mln)
Net debt / cash ($ mln)
| year | 2024 | 2025 |
|---|---|---|
| cash flow / profit | 1.51x | 1.42x |
| accruals, % of assets | -7.1% | -6.2% |
| USD/IDR | 17831 |
| 1-week | -0.5% |
| 1-month | -1.3% |
| room to 52w-weakest | 2.0% |
| DXY (dollar index) | 99.5 |
| US 10Y | 4.68% |
A weaker rupiah lowers the USD value of Indonesian equities for a foreign holder; for banks, BI's high policy rate (defending the currency) pressures margins.
as of 2026-08-14 (Yahoo)
| Date | Per share | Details | Status | Source |
|---|---|---|---|---|
| 2026-06-19 | 43 IDR | Ex-dividend: 43 IDR per share | Paid | Yahoo Finance (ex-div) |
| 2025-06-17 | 43 IDR | Ex-dividend: 43 IDR per share | Paid | Yahoo Finance (ex-div) |
| 2024-06-13 | 34 IDR | Ex-dividend: 34 IDR per share | Paid | Yahoo Finance (ex-div) |
| 2023-06-05 | 37 IDR | Ex-dividend: 37 IDR per share | Paid | Yahoo Finance (ex-div) |
| 2022-05-23 | 36 IDR | Ex-dividend: 36 IDR per share | Paid | Yahoo Finance (ex-div) |
KASE: status follows wording in the news headline (paid vs intends to pay). Yahoo: amounts are cash dividends per share on ex-dividend dates (UTC calendar date). stockscope.uz (UZ): amounts are per share in UZS by publication date (not necessarily ex-div).
Investor reporting (IR): https://www.mitrakeluarga.com/investor-relations/
Reporting forms detected in loaded periods: ✓ ✓ ✓ (Balance sheet / Profit or loss (P&L) / Cash flows)
Financial results, valuation multiples (P/E, P/B, EV/EBITDA), profitability and dividend yield of Mitra Keluarga Karyasehat (MIKA) — from primary filings.
PT Mitra Keluarga Karyasehat Tbk owns and operates a network of hospitals in Indonesia, primarily located on Java, and also provides healthcare platform services.
See also: Indonesian Stocks (2026): The Cheapest Big Emerging Market · The Cheapest Stocks in the World (2026): What Value Investing Says About Buying Cheap · global valuation map